Riskpilot← Back to searchSign inGet full accessMYOBIOTEC AS
ASActiveOrg 974214458Øklandsvegen 90, 5430 BremnesAnnen forskning og annet utviklingsarbeid innen naturvitenskap og teknikk · NACE 72190Est. 19942 employees
Revenue 2021
NOK 2,7M
+5% vs 2020
EBITDA margin
-338.4%
-14% vs 2020
Equity ratio
51.1%
Financial strength
Net profit 2021
NOK -6,7M
-16% vs 2020
| Revenue | NOK 2,7M | +5% |
| EBITDA | NOK -9,1M | -14% |
| Net profit | NOK -6,7M | -16% |
| Total assets | NOK 18,3M | +18% |
| Equity | NOK 9,4M | +24% |
| Employees | 2 | — |
Legal name
MYOBIOTEC AS
Org number
974214458
Legal form
Aksjeselskap
NACE code
72190 · Annen forskning og annet utviklingsarbeid innen naturvitenskap og teknikk
Founded
13. desember 1994
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Forsking og utvikling i heile verdikjeden knytta til fiskevelferd og råstoffkvalitet for fisk, samt teknologi og miljøparameter knytta til dette, nye produkt, kommunikasjon av kunnskap og sal av fou-tenester.
Address
Øklandsvegen 90, 5430 Bremnes
Phone
+4753428200
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 740 | 1 768 | 2 227 | 2 661 | 1 379 | 486 | 331 | 0 | 650 | 3 193 | 2 143 | 3 589 | 2 575 | 2 696 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −1 059 | −1 080 | −2 886 | −2 020 | −2 180 |
| EBITDA | 1 603 | 1 506 | 2 047 | 2 602 | 1 346 | 468 | 315 | −16 | −14 | −8 309 | −9 257 | −8 636 | −8 014 | −9 123 |
| Depreciation & amort. | −192 | −197 | −194 | −215 | −200 | −191 | −199 | −1 613 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 411 | 1 309 | 1 854 | 2 388 | 1 146 | 277 | 115 | −1 629 | −14 | −8 309 | −9 257 | −8 636 | −8 014 | −9 123 |
| Net financials | 259 | −3 | 14 | 17 | 11 | 4 | 1 | 0 | 4 | −0 | −4 886 | 14 | 18 | −2 |
| Profit before tax | 1 670 | 1 306 | 1 868 | 2 405 | 1 157 | 281 | 117 | −1 629 | −10 | −8 309 | −14 143 | −8 622 | −7 996 | −9 125 |
| Tax | 468 | 369 | 515 | 667 | 313 | 43 | 32 | −425 | 5 | −2 061 | −2 420 | −2 340 | −2 167 | −2 387 |
| Net profit | 1 203 | 937 | 1 353 | 1 738 | 844 | 238 | 85 | −1 204 | −15 | −6 248 | −11 723 | −6 282 | −5 829 | −6 739 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6 663 | 7 512 | 9 009 | 11 334 | 7 176 | 7 128 | 7 831 | 6 333 | 5 674 | 15 939 | 13 809 | 12 753 | 15 573 | 18 307 |
| Equity | — | — | 5 733 | 5 718 | 6 562 | 6 800 | 6 886 | 5 682 | 5 667 | 6 612 | 3 557 | 5 643 | 7 573 | 9 359 |
| Long-term debt | 0 | 0 | 0 | 0 | 285 | 259 | 239 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 471 | 380 | 1 860 | 4 215 | 329 | 69 | 706 | 651 | 7 | 9 327 | 10 252 | 7 110 | 8 000 | 8 948 |
| Total debt | 1 888 | 1 799 | 3 276 | 5 616 | 614 | 328 | 945 | 651 | 7 | 9 327 | 10 252 | 7 110 | 8 000 | 8 948 |
EBITDA margin
-338.4%
This company
15.8%
Market median
-2242% vs market
20082021
Equity ratio
51.1%
This company
38.2%
Market median
+34% vs market
20082021
Return on equity
-72.0%
This company
18.4%
Market median
-491% vs market
20082021
Net profit margin
-250.0%
This company
8.1%
Market median
-3186% vs market
20082021
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20082021
Debt / equity
0.96×
This company
0.62×
Market median
+55% vs market
20082021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LK Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bremnes Seashore As | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bremnes Seashore As
MYOBIOTEC AS Board members of MYOBIOTEC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Laila Knarvik | Chief Executive Officer | 0 companies |
| Einar Eide | Board of Directors | 0 companies |
| Bjarte Salomonsen | Board of Directors | 0 companies |
| Olav Svendsen | Chairman | 0 companies |
| Simon Nesse Økland | Board of Directors | 0 companies |